查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1485004

活細胞成像市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品、應用、技術、最終用戶、地區和競爭細分，2019-2029F

Live Cell Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Technology, By End-Users, By Region, and By Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年全球活細胞成像市場價值為 28.6 億美元，到 2029 年預測期內將以 11.04% 的複合年成長率強勁成長。 -使用顯微鏡和成像技術的時間。與傳統的固定細胞成像不同，傳統的固定細胞成像涉及細胞的固定和染色以進行靜態分析，活細胞成像可以動態可視化活體或體外細胞培養物中發生的細胞過程、行為和相互作用。活細胞成像通常涉及使用配備靈敏探測器、高解析度物鏡和針對捕獲動態細胞事件而最佳化的成像軟體的專用顯微鏡。各種顯微鏡技術，包括寬視野顯微鏡、共焦顯微鏡、多光子顯微鏡和超解析度顯微鏡，可用於活細胞成像，每種技術在空間解析度、成像深度和對比度增強方面都具有獨特的優勢。螢光探針、染料和基因編碼標記通常用於標記特定的細胞結構、蛋白質、細胞器和生物分子，以便在活細胞成像實驗中可視化。螢光標記使研究人員能夠選擇性地突出和追蹤感興趣的細胞成分，例如細胞核、細胞骨架、粒線體、內質網和膜受體，從而促進即時細胞動力學和功能的研究。活細胞成像實驗是使用專門的細胞培養系統和成像室進行的，這些系統和成像室可以維持細胞生長、活力和功能的最佳生理條件。溫控培養箱、濕潤環境和 CO2 調節氣氛可確保長時間實驗期間細胞存活和成像穩定性的穩定條件。

市場概況
預測期 2025-2029
2023 年市場規模 28.6億美元
2029 年市場規模 53.7億美元
2024-2029 年複合年成長率 11.04%
成長最快的細分市場 延時顯微鏡
最大的市場 北美洲

研究複雜細胞過程和動態相互作用對高解析度成像技術的需求不斷成長，推動了對活細胞成像系統的需求。研究人員和醫療保健專業人員尋求先進的成像技術，能夠捕捉具有高空間和時間解析度的詳細、即時的活細胞影像。活細胞成像透過促進即時監測細胞對候選藥物的反應、評估藥物功效和評估潛在毒性，在藥物發現和開發中發揮至關重要的作用。製藥業越來越依賴活細胞成像系統來加速藥物開發流程、降低成本並提高新治療干預措施的成功率。顯微鏡技術、成像感測器和分析軟體的不斷進步增強了活細胞成像系統的功能和性能。顯微鏡技術的創新使研究人員能夠以更高的靈敏度、速度和精度捕捉活細胞的高解析度影像，從而推動市場的採用和擴張。

主要市場促進因素

對高解析度成像技術的需求不斷增加

擴大藥物發現與開發的應用

顯微鏡和成像軟體的技術進步

主要市場挑戰

光毒性和光漂白

標準化和可重複性

主要市場趨勢

器官晶片 (OOC) 和微流體技術的出現

細分市場洞察

技術洞察

最終使用者見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球活細胞成像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（儀器、消耗品、軟體、服務）
    • 依應用（細胞生物學、幹細胞、發育生物學、藥物發現）
    • 依技術（延時顯微鏡、光漂白後的螢光恢復、高內涵篩選、螢光共振能量轉移等）
    • 由最終用戶（製藥和生物技術公司、學術和研究機構、合約研究組織）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖

第 6 章：北美活細胞成像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按申請
    • 依技術
    • 由最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲活細胞成像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按申請
    • 依技術
    • 由最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區活細胞成像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按申請
    • 依技術
    • 由最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲活細胞成像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按申請
    • 依技術
    • 由最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲活細胞成像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按申請
    • 依技術
    • 由最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最近的發展

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies Inc.
  • Blue-Ray Biotech Corp.
  • CytoSMART Technologies (Axion BioSystems, Inc)
  • Curiosis Inc.
  • Carl Zeiss AG
  • Thermo Fisher Scientific Inc.
  • Perkin Elmer Inc.
  • Danaher Corporation
  • Nikon Corporation

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 23943

Global Live Cell Imaging Market was valued at USD 2.86 billion in 2023 and will see an robust growth in the forecast period at a CAGR of 11.04% through 2029. Live cell imaging is a scientific technique that allows researchers to observe and analyze living cells in real-time using microscopy and imaging technologies. Unlike traditional fixed-cell imaging, which involves the fixation and staining of cells for static analysis, live cell imaging enables the dynamic visualization of cellular processes, behaviors, and interactions as they occur within living organisms or in vitro cell cultures. Live cell imaging typically involves the use of specialized microscopes equipped with sensitive detectors, high-resolution objectives, and imaging software optimized for capturing dynamic cellular events. Various microscopy techniques, including widefield microscopy, confocal microscopy, multiphoton microscopy, and super-resolution microscopy, can be employed for live cell imaging, each offering unique advantages in terms of spatial resolution, imaging depth, and contrast enhancement. Fluorescent probes, dyes, and genetically encoded markers are commonly used to label specific cellular structures, proteins, organelles, and biomolecules for visualization in live cell imaging experiments. Fluorescent labeling enables researchers to selectively highlight and track cellular components of interest, such as nuclei, cytoskeleton, mitochondria, endoplasmic reticulum, and membrane receptors, facilitating the study of cellular dynamics and functions in real-time. Live cell imaging experiments are performed using specialized cell culture systems and imaging chambers that maintain optimal physiological conditions for cell growth, viability, and function. Temperature-controlled incubators, humidified environments, and CO2-regulated atmospheres ensure stable conditions for cell survival and imaging stability during prolonged experiments.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 2.86 Billion
Market Size 2029USD 5.37 Billion
CAGR 2024-202911.04%
Fastest Growing SegmentTime Lapse Microscopy
Largest MarketNorth America

The growing need for high-resolution imaging techniques to study complex cellular processes and dynamic interactions drives the demand for live cell imaging systems. Researchers and healthcare professionals seek advanced imaging technologies capable of capturing detailed, real-time images of living cells with high spatial and temporal resolution. Live cell imaging plays a crucial role in drug discovery and development by facilitating the real-time monitoring of cellular responses to drug candidates, assessing drug efficacy, and evaluating potential toxicity. The pharmaceutical industry increasingly relies on live cell imaging systems to accelerate the drug development pipeline, reduce costs, and improve the success rate of new therapeutic interventions. Continuous advancements in microscopy techniques, imaging sensors, and analysis software enhance the capabilities and performance of live cell imaging systems. Innovations in microscopy technology enable researchers to capture high-resolution images of living cells with improved sensitivity, speed, and precision, driving market adoption and expansion.

Key Market Drivers

Increasing Demand for High-Resolution Imaging Techniques

High-resolution imaging techniques enable researchers to visualize intricate details of cellular structures and dynamic processes in real-time. Live cell imaging allows for the observation of cellular events such as cell division, migration, signaling, and interaction with high clarity and precision. Live cell imaging provides valuable insights into the functional behavior of cells under various physiological and pathological conditions. High-resolution imaging enables researchers to study subcellular structures, organelle dynamics, and molecular interactions within living cells, contributing to a deeper understanding of cellular function and regulation. High-resolution live cell imaging is instrumental in studying the mechanisms underlying various diseases, including cancer, neurodegenerative disorders, infectious diseases, and metabolic syndromes. Researchers use live cell imaging to investigate disease progression, identify disease biomarkers, and develop targeted therapeutic interventions. High-resolution live cell imaging plays a crucial role in drug discovery and development by facilitating the screening, evaluation, and optimization of potential drug candidates. Researchers use live cell imaging assays to assess drug efficacy, toxicity, and pharmacokinetics in physiologically relevant cellular models, accelerating the drug development pipeline and improving drug safety profiles.

High-resolution live cell imaging allows researchers to monitor cellular responses to external stimuli, environmental cues, and therapeutic interventions in real-time. By visualizing cellular dynamics at high resolution, researchers can track changes in cell morphology, behavior, and function, enabling precise quantification and analysis of cellular responses under dynamic conditions. Continuous advancements in microscopy techniques, imaging sensors, and analysis software enhance the spatial and temporal resolution of live cell imaging systems. High-resolution imaging technologies such as confocal microscopy, multi-photon microscopy, and super-resolution microscopy enable researchers to achieve subcellular-level resolution and capture dynamic cellular events with unprecedented detail and clarity. High-resolution live cell imaging is increasingly being applied in translational research and clinical diagnostics to visualize disease processes, monitor treatment responses, and predict patient outcomes. By integrating high-resolution imaging techniques with clinical workflows, researchers and clinicians can gain insights into disease pathology, identify prognostic markers, and personalize treatment strategies for improved patient care. This factor will help in the development of the Global Live Cell Imaging Market.

Expanding Applications in Drug Discovery and Development

Live cell imaging allows researchers to visualize and monitor cellular responses to drug candidates in real-time. By observing how cells react to various compounds, researchers can assess drug efficacy, toxicity, and mechanisms of action more accurately than with traditional endpoint assays. Live cell imaging systems can be integrated with automated platforms to conduct high-throughput screening of large compound libraries. This enables researchers to rapidly identify lead compounds with desired biological activities and optimize drug candidates for further development. Live cell imaging helps identify novel drug targets by studying cellular processes involved in disease pathology. By observing dynamic changes in cell morphology, proliferation, and function, researchers can pinpoint key signaling pathways and molecular targets for therapeutic intervention. Live cell imaging enables researchers to characterize the mechanisms of action of drugs at the cellular level. By tracking drug interactions with target molecules, observing changes in cellular morphology, and monitoring intracellular signaling pathways, researchers can elucidate how drugs exert their effects and optimize treatment regimens.

Live cell imaging allows for the prediction of drug response based on individual cellular phenotypes and genetic profiles. By analyzing how different cell types or patient-derived cells respond to drug treatments, researchers can tailor therapies to specific patient populations, improving treatment outcomes and minimizing adverse effects. Live cell imaging helps researchers study mechanisms of drug resistance in diseases such as cancer. By observing how cancer cells adapt and develop resistance to chemotherapy or targeted therapies, researchers can identify new strategies to overcome resistance and enhance treatment efficacy. Live cell imaging provides valuable insights into the validity and relevance of preclinical models for drug discovery. By comparing cellular responses observed in live cell imaging assays with clinical outcomes, researchers can validate preclinical models, identify biomarkers of drug response, and improve the translatability of preclinical findings to human disease. This factor will pace up the demand of the Global Live Cell Imaging Market.

Technological Advancements in Microscopy and Imaging Software

Advances in microscopy technology enable the capture of high-resolution images with improved spatial and temporal resolution. Higher resolution allows researchers to visualize cellular structures and dynamic processes at finer detail and track rapid changes in real-time, enhancing the accuracy and reliability of live cell imaging experiments. Super-resolution microscopy techniques, such as structured illumination microscopy (SIM), stimulated emission depletion microscopy (STED), and single-molecule localization microscopy (SMLM), push the limits of optical resolution beyond the diffraction limit. These techniques enable researchers to achieve subcellular-level resolution and visualize molecular structures and interactions with unprecedented clarity and precision. Advanced live cell imaging systems integrate multiple imaging modalities, such as fluorescence, brightfield, phase contrast, and differential interference contrast (DIC) microscopy, to provide complementary information about cellular morphology, dynamics, and function. Multi-modal imaging enhances the versatility and capabilities of live cell imaging platforms, enabling researchers to study a wide range of biological phenomena with greater depth and insight. Continuous improvements in imaging sensors, detectors, and light sources enhance the speed and sensitivity of live cell imaging systems. Faster imaging speeds enable researchers to capture rapid cellular events and dynamic processes with minimal motion blur, while increased sensitivity improves the detection of weak fluorescent signals and reduces phototoxicity and photobleaching effects.

Light sheet microscopy, also known as selective plane illumination microscopy (SPIM), facilitates high-speed, high-resolution imaging of large specimens and three-dimensional (3D) cellular structures. Light sheet microscopy minimizes photodamage to live cells by illuminating only the focal plane of interest, enabling long-term, non-invasive imaging of dynamic biological processes in living organisms and tissue samples. Sophisticated imaging software and analysis tools enable researchers to process, analyze, and visualize large volumes of live cell imaging data with greater efficiency and accuracy. Advanced algorithms for image segmentation, feature extraction, and quantification facilitate automated image analysis, object tracking, and data mining, accelerating the interpretation and extraction of meaningful insights from live cell imaging experiments. Integration of AI and ML algorithms into live cell imaging systems enhances automated image analysis and data interpretation capabilities. AI-based approaches enable the identification of complex cellular phenotypes, classification of cellular events, and prediction of drug responses based on large-scale imaging datasets, empowering researchers to extract valuable biological insights and discover novel patterns and correlations within live cell imaging data. This factor will accelerate the demand of the Global Live Cell Imaging Market

Key Market Challenges

Phototoxicity and Photobleaching

Phototoxicity refers to the harmful effects of light exposure on living cells during imaging experiments. Prolonged or intense illumination can induce cellular stress, DNA damage, and cell death, compromising the integrity of experimental results and affecting the viability and behavior of cells under observation. Phototoxicity can introduce artifacts and distortions in live cell imaging data, leading to inaccurate interpretation and analysis of cellular processes. Photodamaged cells may exhibit abnormal morphology, altered physiological responses, and impaired function, confounding experimental observations and undermining the reliability of experimental outcomes. Phototoxicity can reduce cell viability and compromise the physiological relevance of live cell imaging experiments. Photodamaged cells may undergo apoptosis, necrosis, or senescence, limiting the duration and quality of imaging studies and impeding the study of long-term cellular dynamics and behaviors. Photobleaching refers to the irreversible loss of fluorescence intensity in fluorescently labeled molecules due to repeated light exposure. Photobleaching limits the duration and quality of live cell imaging experiments, as fluorescent signals diminish over time, reducing signal-to-noise ratios and impairing the detection and quantification of cellular structures and processes. Photobleaching reduces the brightness and contrast of fluorescent signals, compromising image quality and resolution in live cell imaging experiments. Diminished fluorescence intensity makes it challenging to distinguish between specific and nonspecific signals, complicating image analysis and interpretation and limiting the sensitivity and accuracy of experimental results. Phototoxicity and photobleaching impose constraints on the duration and frequency of live cell imaging experiments. Researchers must balance the need for high-quality imaging data with the risk of cellular damage and photobleaching effects, optimizing imaging parameters and experimental conditions to minimize adverse effects on cell viability and imaging outcomes.

Standardization and Reproducibility

Live cell imaging experiments are susceptible to variability in experimental conditions, including cell culture protocols, imaging techniques, equipment settings, and environmental factors. Minor variations in these parameters can significantly impact imaging outcomes and experimental results, leading to inconsistencies and difficulties in replicating findings across different research studies. The absence of standardized protocols and guidelines for live cell imaging contributes to variability and inconsistency in experimental procedures and data interpretation. Researchers may use different imaging platforms, software tools, and analytical methods, making it challenging to compare results and reproduce experimental findings across laboratories and research groups. Live cell imaging experiments may be conducted using a wide range of microscopy systems, cameras, objectives, filters, and imaging software, each with its own specifications and performance characteristics. Variations in imaging setups and equipment configurations can introduce biases and errors in imaging data, hindering the reproducibility and reliability of experimental results. Inconsistent sample preparation techniques, cell culture conditions, and handling procedures can affect cell viability, morphology, and behavior during live cell imaging experiments. Variability in sample preparation and handling practices can lead to differences in cellular responses and imaging outcomes, making it challenging to replicate experimental conditions and validate findings across studies. Image analysis in live cell imaging experiments often involves subjective judgments and manual interventions, which can introduce bias and variability in data interpretation. Differences in image processing algorithms, segmentation methods, and quantification criteria can lead to inconsistencies in image analysis and result interpretation, affecting the reproducibility and reliability of experimental findings. Publication bias and selective reporting of positive results in scientific literature can contribute to challenges in reproducibility and data interpretation in live cell imaging studies. Negative or inconclusive findings may be underrepresented or omitted from publications, leading to overestimation of experimental outcomes and limited transparency in reporting experimental methods and results.

Key Market Trends

Emergence of Organ-on-Chip (OOC) and Microfluidics Technologies

Organ-on-Chip (OOC) and Microfluidics platforms allow researchers to replicate complex physiological microenvironments and tissue architectures in vitro. These platforms feature microfluidic channels, chambers, and scaffolds that mimic the spatial organization, mechanical cues, and biochemical gradients present in living tissues, enabling more physiologically relevant cell culture and imaging experiments. Organ-on-Chip (OOC) and Microfluidics technologies are integrated with live cell imaging systems to facilitate real-time visualization and analysis of cellular responses within micro engineered tissue models. Live cell imaging enables researchers to monitor cell behavior, migration, differentiation, and interactions within microfluidic devices, providing insights into dynamic cellular processes and tissue responses under controlled experimental conditions. Organ-on-Chip (OOC) and Microfluidics platforms enable high-throughput screening of drug candidates and therapeutic compounds using live cell imaging assays. By culturing cells in miniature tissue models within microfluidic devices, researchers can screen large libraries of compounds, monitor drug responses, and assess pharmacological effects on cellular physiology and function, accelerating drug discovery and development efforts. Organ-on-Chip (OOC) and Microfluidics technologies support long-term monitoring of cell behavior and responses to dynamic microenvironmental cues. Continuous perfusion of cell culture media, precise control of fluid flow rates, and automated imaging systems allow researchers to sustain cell viability, maintain homeostasis, and monitor cellular dynamics over extended periods, facilitating the study of chronic diseases, tissue regeneration, and developmental processes. Organ-on-Chip (OOC) and Microfluidics platforms integrate multi-modal imaging techniques, such as fluorescence microscopy, confocal microscopy, and live-cell imaging, to capture comprehensive information about cellular morphology, function, and molecular signaling within micro engineered tissues. Multi-modal imaging enables researchers to visualize spatial and temporal changes in cellular behavior, analyze subcellular structures, and investigate molecular interactions in real-time, enhancing the depth and resolution of live cell imaging experiments.

Segmental Insights

Technology Insights

The Time Lapse Microscopy segment is projected to experience rapid growth in the Global Live Cell Imaging Market during the forecast period. Time lapse microscopy allows researchers to capture real-time images of cellular processes, such as cell division, migration, and interactions, over extended periods. This dynamic visualization provides valuable insights into the behavior and dynamics of living cells, enabling the study of biological phenomena with high temporal resolution. Time lapse microscopy plays a crucial role in drug discovery and development by facilitating the real-time monitoring of cellular responses to drug candidates and environmental stimuli. Researchers use time-lapse imaging to assess drug efficacy, toxicity, and pharmacokinetics, accelerating the drug screening process and improving the selection of lead compounds for further development. Time lapse microscopy enables the study of dynamic cellular processes, including cell motility, signaling pathways, and morphological changes, in response to various stimuli and experimental conditions. This longitudinal analysis provides comprehensive insights into the underlying mechanisms governing cellular behavior and function, advancing our understanding of complex biological systems. The integration of three-dimensional (3D) and four-dimensional (4D) imaging techniques into time-lapse microscopy allows researchers to capture spatial and temporal dynamics of cellular structures and interactions in three dimensions. These advanced imaging modalities enhance the spatial resolution and depth perception of time-lapse imaging, enabling more accurate reconstruction and analysis of complex biological processes. Time lapse microscopy is widely adopted across various fields of life sciences research, including cell biology, developmental biology, neuroscience, and cancer research. Its versatility and applicability to a wide range of biological questions make it a valuable tool for studying fundamental biological processes and disease mechanisms.

End-Users Insights

The Pharmaceutical and Biotechnology Companies segment is projected to experience rapid growth in the Global Live Cell Imaging Market during the forecast period. Pharmaceutical and biotechnology companies heavily rely on live cell imaging technologies to accelerate drug discovery and development processes. Live cell imaging enables real-time visualization and analysis of cellular responses to drug candidates, helping researchers identify promising leads, assess drug efficacy, and evaluate potential side effects more efficiently. Live cell imaging systems can be integrated with automated imaging platforms to conduct high-throughput screening of compound libraries for drug discovery purposes. Pharmaceutical and biotechnology companies utilize live cell imaging assays to screen large numbers of compounds, identify hits, and prioritize lead candidates for further optimization and preclinical testing. The shift towards personalized medicine and targeted therapies has increased the demand for live cell imaging technologies in pharmaceutical and biotechnology research. Live cell imaging allows for the characterization of patient-derived cells and tissues, enabling researchers to tailor treatment strategies based on individual genetic profiles and disease phenotypes. Live cell imaging plays a crucial role in stem cell research and regenerative medicine, areas of significant interest for pharmaceutical and biotechnology companies. These companies utilize live cell imaging to study stem cell differentiation, proliferation, and tissue regeneration processes, with the aim of developing novel cell-based therapies for a wide range of diseases and conditions. Continuous advancements in live cell imaging technology, including improvements in microscopy techniques, imaging sensors, and analysis software, have enhanced the capabilities and accessibility of live cell imaging systems for pharmaceutical and biotechnology applications. These technological advancements enable researchers to capture high-resolution, real-time images of cellular processes with greater accuracy and precision.

Regional Insights

North America emerged as the dominant region in the Global Live Cell Imaging Market in 2023. North America boasts a robust infrastructure for biomedical research, including state-of-the-art laboratories, academic institutions, and research centers. The region is home to leading universities, medical schools, and biotechnology companies that drive innovation and technological advancements in live cell imaging. The healthcare and pharmaceutical sectors in North America are highly developed and invest significantly in research and development. The demand for live cell imaging technologies is fueled by the need for advanced tools and techniques to study disease mechanisms, drug interactions, and cellular processes, driving market growth in the region. North American companies and research institutions actively engage in collaborations and partnerships to accelerate product development, innovation, and commercialization of live cell imaging technologies. These collaborations foster knowledge exchange, access to funding, and the development of novel applications, enhancing the competitiveness of the region in the global market. The regulatory environment in North America is conducive to the development and commercialization of life science technologies, including live cell imaging systems. Regulatory agencies such as the FDA (Food and Drug Administration) provide clear guidelines and pathways for product approval, ensuring safety, efficacy, and quality standards are met.

Key Market Players

Bio-Rad Laboratories, Inc.

Agilent Technologies Inc.

Blue-Ray Biotech Corp.

CytoSMART Technologies (Axion BioSystems, Inc)

Curiosis Inc.

Carl Zeiss AG

Thermo Fisher Scientific Inc.

Perkin Elmer Inc

Danaher Corporation

Nikon Corporation

Report Scope:

In this report, the Global Live Cell Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Live Cell Imaging Market, By Product:

    Instruments Consumables Software Services

Live Cell Imaging Market, By Application:

    Cell Biology Stem Cells Developmental Biology Drug Discovery

Live Cell Imaging Market, By Technology:

    Time Lapse Microscopy Fluorescence Recovery After Photo Bleaching High Content Screening Fluorescence Resonance Energy Transfer Others

Live Cell Imaging Market, By End-Users:

    Pharmaceutical and Biotechnology Companies Academic and Research Institutes Contract Research Organizations

Live Cell Imaging Market, By Region:

    North America

United States

Canada

Mexico

    Europe

Germany

United Kingdom

France

Italy

Spain

    Asia-Pacific

China

Japan

India

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Live Cell Imaging Market.

Available Customizations:

Global Live Cell Imaging market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Live Cell Imaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Instruments, Consumables, Software, Services)
    • 5.2.2. By Application (Cell Biology, Stem Cells, Developmental Biology, Drug Discovery)
    • 5.2.3. By Technology (Time Lapse Microscopy, Fluorescence Recovery After Photo Bleaching, High Content Screening, Fluorescence Resonance Energy Transfer, Others)
    • 5.2.4. By End-Users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations)
    • 5.2.5. By Region
    • 5.2.6. By Company (2023)
  • 5.3. Market Map

6. North America Live Cell Imaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Technology
    • 6.2.4. By End-Users
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Live Cell Imaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Technology
        • 6.3.1.2.4. By End-Users
    • 6.3.2. Canada Live Cell Imaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Technology
        • 6.3.2.2.4. By End-Users
    • 6.3.3. Mexico Live Cell Imaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Technology
        • 6.3.3.2.4. By End-Users

7. Europe Live Cell Imaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Technology
    • 7.2.4. By End-Users
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Live Cell Imaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By End-Users
    • 7.3.2. United Kingdom Live Cell Imaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By End-Users
    • 7.3.3. Italy Live Cell Imaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By End-Users
    • 7.3.4. France Live Cell Imaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By End-Users
    • 7.3.5. Spain Live Cell Imaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By End-Users

8. Asia-Pacific Live Cell Imaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Technology
    • 8.2.4. By End-Users
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Live Cell Imaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By End-Users
    • 8.3.2. India Live Cell Imaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By End-Users
    • 8.3.3. Japan Live Cell Imaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By End-Users
    • 8.3.4. South Korea Live Cell Imaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By End-Users
    • 8.3.5. Australia Live Cell Imaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By End-Users

9. South America Live Cell Imaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Technology
    • 9.2.4. By End-Users
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Live Cell Imaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By End-Users
    • 9.3.2. Argentina Live Cell Imaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By End-Users
    • 9.3.3. Colombia Live Cell Imaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By End-Users

10. Middle East and Africa Live Cell Imaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Technology
    • 10.2.4. By End-Users
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Live Cell Imaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By End-Users
    • 10.3.2. Saudi Arabia Live Cell Imaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By End-Users
    • 10.3.3. UAE Live Cell Imaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By End-Users

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Bio-Rad Laboratories, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Agilent Technologies Inc.
  • 14.3. Blue-Ray Biotech Corp.
  • 14.4. CytoSMART Technologies (Axion BioSystems, Inc)
  • 14.5. Curiosis Inc.
  • 14.6. Carl Zeiss AG
  • 14.7. Thermo Fisher Scientific Inc.
  • 14.8. Perkin Elmer Inc.
  • 14.9. Danaher Corporation
  • 14.10.Nikon Corporation

15. Strategic Recommendations

16. About Us & Disclaimer